These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25132665)

  • 41. Synthesis, anti-HBV activity and renal cell toxicity evaluation of mixed phosphonate prodrugs of adefovir.
    Fu XZ; Ou Y; Pei JY; Liu Y; Li J; Zhou W; Lan YY; Wang AM; Wang YL
    Eur J Med Chem; 2012 Mar; 49():211-8. PubMed ID: 22305613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus.
    Manna AK; Kumar A; Ray U; Das S; Basu G; Roy S
    Antiviral Res; 2013 Mar; 97(3):223-6. PubMed ID: 23291201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents?
    Procházková E; Hřebabecký H; Dejmek M; Šála M; Šmídková M; Tloušťová E; Zborníková E; Eyer L; Růžek D; Nencka R
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126897. PubMed ID: 31882298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C replication inhibitors that target the viral NS4B protein.
    Miller JF; Chong PY; Shotwell JB; Catalano JG; Tai VW; Fang J; Banka AL; Roberts CD; Youngman M; Zhang H; Xiong Z; Mathis A; Pouliot JJ; Hamatake RK; Price DJ; Seal JW; Stroup LL; Creech KL; Carballo LH; Todd D; Spaltenstein A; Furst S; Hong Z; Peat AJ
    J Med Chem; 2014 Mar; 57(5):2107-20. PubMed ID: 23544424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of 9-[1-(1 -hydroxyethyl)-3-(phosphonomethoxy)propyl]adenine and prodrug as possible antiviral agents.
    Ghosh A; El-Kattan Y; Wu M; Lin TH; Vadlakonda S; Kotian PL; Babu YS; Chand P
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1587-95. PubMed ID: 16438036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of bovine viral diarrhea virus in vitro by xanthohumol: comparisons with ribavirin and interferon-alpha and implications for the development of anti-hepatitis C virus agents.
    Zhang N; Liu Z; Han Q; Chen J; Lou S; Qiu J; Zhang G
    Eur J Pharm Sci; 2009 Nov; 38(4):332-40. PubMed ID: 19720145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.
    Hong W; Lang Y; Li T; Zeng Z; Song Y; Wu Y; Li W; Cao Z
    J Biol Chem; 2015 Sep; 290(38):23254-63. PubMed ID: 26251517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Focus.
    Samuel D
    J Hepatol; 2010 Jan; 52(1):3-4. PubMed ID: 19923033
    [No Abstract]   [Full Text] [Related]  

  • 51. Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon.
    Saito Y; Escuret V; Durantel D; Zoulim F; Schinazi RF; Agrofoglio LA
    Bioorg Med Chem; 2003 Aug; 11(17):3633-9. PubMed ID: 12901908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).
    McGuigan C; Kelleher MR; Perrone P; Mulready S; Luoni G; Daverio F; Rajyaguru S; Le Pogam S; Najera I; Martin JA; Klumpp K; Smith DB
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4250-4. PubMed ID: 19505826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
    Sinokrot H; Smerat T; Najjar A; Karaman R
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
    Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
    Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
    Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects.
    Zuwala K; Riber CF; Løvschall KB; Andersen AHF; Sørensen L; Gajda P; Tolstrup M; Zelikin AN
    J Control Release; 2018 Apr; 275():53-66. PubMed ID: 29432822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategies for ribavirin prodrugs and delivery systems for reducing the side-effect hemolysis and enhancing their therapeutic effect.
    Guo H; Sun S; Yang Z; Tang X; Wang Y
    J Control Release; 2015 Jul; 209():27-36. PubMed ID: 25883028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular metabolism and potential cardiotoxicity of a β-D-2'-
    Tao S; Zhou L; Zhang H; Zhou S; Amiralaei S; Shelton J; Ehteshami M; Jiang Y; Amblard F; Coats SJ; Schinazi RF
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):204-224. PubMed ID: 31595843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SATE pronucleotide approaches: an overview.
    Peyrottes S; Egron D; Lefebvre I; Gosselin G; Imbach JL; Périgaud C
    Mini Rev Med Chem; 2004 May; 4(4):395-408. PubMed ID: 15134542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological evaluation of a novel β-D-2'-deoxy-2'-α-fluoro-2'-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection.
    Li E; Wang Y; Yu W; Lv Z; Peng Y; Liu B; Li S; Ho W; Wang Q; Li H; Chang J
    Eur J Med Chem; 2018 Jan; 143():107-113. PubMed ID: 29172078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.